ARCHIVES

Mendelsohn Defends ImClone’s Actions And His Role In Development of C225

This article is from The Cancer Letter archive.

Vol. 28 No. 38 | October 18, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: National Patient Advocates Foundation Formed To Seek Health Insurance Reform

November 15, 1996

NCI TO Issue RFA For Gene Therapy Studies; $20 Mil. Se-Aside Ok’d

January 10, 1992

In Brief: Data Availability From Cancer Survey Presents Problems – Who Gets It first, Confidentiality

August 30, 1974

Rituximab and Fludarabine Combination Produces Long-Term Remissions in CLL

March 25, 2011

Rabson’s Group Hears Suggestions On Carcinogenesis

November 25, 1977

In Brief: Rall Says He’ll Return Money To NCI If There Isn’t Any Left; OMB Releases 28 Positions For NTP

February 1, 1980